| Entry |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Name | Aspirin aluminum (JP18) | ||||||||
| Formula | (C9H7O4)2. Al. OH | ||||||||
| Exact mass | 402.0531 | ||||||||
| Mol weight | 402.2878 | ||||||||
| Structure |  | ||||||||
| Simcomp | |||||||||
| Class | Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent Anti-inflammatory DG01504 Nonsteroidal anti-inflammatory drug (NSAID) DG01909 Anti-inflammatory drug, salicylic acid derivatives | ||||||||
| Remark |
| ||||||||
| Efficacy | Analgesic, COX inhibitor | ||||||||
| Comment | Salicylic acid derivative | ||||||||
| Target | PTGS1 (COX1) [HSA:5742] [KO:K00509] PTGS2 (COX2) [HSA:5743] [KO:K11987] | ||||||||
| Pathway |
| ||||||||
| Interaction | |||||||||
| Structure map |
| ||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] A ALIMENTARY TRACT AND METABOLISM A01 STOMATOLOGICAL PREPARATIONS A01A STOMATOLOGICAL PREPARATIONS A01AD Other agents for local oral treatment A01AD05 Acetylsalicylic acid D05181 Aspirin aluminum (JP18) B BLOOD AND BLOOD FORMING ORGANS B01 ANTITHROMBOTIC AGENTS B01A ANTITHROMBOTIC AGENTS B01AC Platelet aggregation inhibitors excl. heparin B01AC06 Acetylsalicylic acid D05181 Aspirin aluminum (JP18) N NERVOUS SYSTEM N02 ANALGESICS N02B OTHER ANALGESICS AND ANTIPYRETICS N02BA Salicylic acid and derivatives N02BA01 Acetylsalicylic acid D05181 Aspirin aluminum (JP18) Classification of Japanese OTC drugs [BR:br08313] Agents for nervous and sensory systems 01 Cold remedy (oral use) D05181 Aspirin aluminum (JP18) 03 Antipyretic analgesic agents D05181 Aspirin aluminum (JP18) Risk category of Japanese OTC drugs [BR:br08312] Designated second-class OTC drugs Inorganic and organic chemicals Aspirin D05181 Aspirin aluminum (JP18) Second-class OTC drugs Inorganic and organic chemicals Aspirin D05181 Aspirin aluminum (JP18) Animal drugs in Japan [BR:br08331] 91 Agents affecting nervous system 913 Antipyretics, analgesics and antiinflammatory 9131 Salicylic acids, derivatives and preparations D05181 Aspirin aluminum Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent DG00015 Acetylsalicylic acid D05181 Aspirin aluminum Anti-inflammatory DG01504 Nonsteroidal anti-inflammatory drug (NSAID) DG01909 Anti-inflammatory drug, salicylic acid derivatives DG00015 Acetylsalicylic acid D05181 Aspirin aluminum Target-based classification of drugs [BR:br08310] Enzymes Oxidoreductases (EC1) Prostaglandin synthase PTGS1 (COX1) D05181 Aspirin aluminum (JP18) PTGS2 (COX2) D05181 Aspirin aluminum (JP18) Drugs listed in the Japanese Pharmacopoeia [BR:br08311] Chemicals D05181 Aspirin aluminum Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01712 Antiplatelet agent DG00015 Acetylsalicylic acid Anti-inflammatory DG01504 Nonsteroidal anti-inflammatory drug (NSAID) DG01909 Anti-inflammatory drug, salicylic acid derivatives DG00015 Acetylsalicylic acid | ||||||||
| Other DBs |
| ||||||||
| KCF data | ATOM 28 1 O0 O 29.8220 -21.0720 #- 2 C6a C 25.5515 -18.9018 3 O6a O 26.9517 -18.9018 #- 4 O6a O 27.9318 -21.2821 5 C7a C 26.9517 -22.2622 6 O7a O 25.5515 -22.2622 7 C8y C 24.5714 -21.2821 8 C8y C 24.5714 -19.8819 9 O6a O 24.9915 -17.6417 10 C1a C 27.4417 -23.5923 11 C8x C 23.3113 -19.1818 12 C8x C 22.1212 -19.8819 13 C8x C 22.1212 -21.2821 14 C8x C 23.3113 -21.9821 15 C6a C 33.6024 -20.6520 16 O6a O 32.2023 -20.6520 #- 17 O6a O 31.2221 -18.2717 18 C7a C 32.2023 -17.2916 19 O7a O 33.6024 -17.2916 20 C8y C 34.5825 -18.2717 21 C8y C 34.5825 -19.6719 22 O6a O 34.1625 -21.9121 23 C1a C 31.7122 -15.9615 24 C8x C 35.8426 -20.3720 25 C8x C 37.0328 -19.6719 26 C8x C 37.0328 -18.2717 27 C8x C 35.8426 -17.5717 28 Z Al 28.9819 -19.4619 #3+ BOND 26 1 2 3 1 2 4 5 2 3 5 6 1 4 6 7 1 5 7 8 1 6 8 2 1 7 2 9 2 8 5 10 1 9 8 11 2 10 11 12 1 11 12 13 2 12 13 14 1 13 7 14 2 14 15 16 1 15 17 18 2 16 18 19 1 17 19 20 1 18 20 21 1 19 21 15 1 20 15 22 2 21 18 23 1 22 21 24 2 23 24 25 1 24 25 26 2 25 26 27 1 26 20 27 2 |